Endometrial Cancer
📧 Sign up to get email alerts when something new happens for Endometrial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial Cancer [Phase 2]
A Phase 2 trial evaluating lenvatinib with pembrolizumab in Black patients with mismatch repair-proficient recurrent endometrial cancer has …
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 trial of NKT3447 in adults with advanced or metastatic solid tumors has been terminated. The study encompassed indications including…
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: Real-time Lymphatic Channel Visualization Improves Bilateral Sentinel Lymph Node Detection in Endometrial Cancer [NA]
A completed clinical trial reports that real-time visualization of lymphatic channels improves bilateral sentinel lymph node detection in en…
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone [Phase 2]
Phase 2 trial in recurrent or refractory endometrial cancer evaluating Olaparib with Durvalumab, Cediranib with Durvalumab, Olaparib with Ca…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) [Phase 2]
Pembrolizumab is being studied in a Phase 2 trial (MK-3475-158/KEYNOTE-158) for advanced solid tumors; the study is currently active but not…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors [Phase 1]
Phase 1a/1b study of TPST-1495 as monotherapy and in combination with pembrolizumab has completed status, spanning multiple solid tumors inc…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Effect of Metformin on Endometrial Thickness in Postmenopausal Breast Cancer Patients Receiving Tamoxifen [NA]
A completed clinical trial investigated whether metformin influences endometrial thickness in postmenopausal breast cancer patients undergoi…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Efficacy of PENS of the Auricle as an Opioid Sparing Postoperative Analgesic Technique in Cancer Endometrium and Cancer Cervix Patients [NA]
Completed clinical trial evaluating the efficacy of auricular PENS (percutaneous electrical nerve stimulation) as an opioid-sparing postoper…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Taste Alteration, Sarcopenia, and Malnutrition in Gynecologic Cancer Patients Receiving Carboplatin-Paclitaxel Chemotherapy
A completed clinical trial in gynecologic cancers evaluated taste alteration, sarcopenia, and malnutrition in patients treated with carbopla…
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: High Intensity Interval Training in Endometrial Cancer [NA]
A completed trial (NCT04025229) evaluated high-intensity interval training in patients with endometrial cancer. Results were posted on 2025-…
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: Sexual Health Integration in Treatment of Gynecological Oncology
Completed clinical trial evaluating integration of sexual health support and counseling into gynecologic oncology care. The study includes p…
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers [Phase 1]
This clinical trial update summarizes the Phase 1 study of STRO-002, an anti-Folate Receptor Alpha antibody-drug conjugate, in ovarian and e…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: Trial of Maintenance With Niraparib- Uterine Serous Carcinoma [Phase 2]
Phase 2 study of Niraparib as maintenance therapy in uterine serous carcinoma and related endometrial cancers has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial Cancer [Phase 2, Phase 3]
A clinical trial update indicates BAT1308 in combination with platinum-containing chemotherapy for first-line treatment of advanced or recur…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: A Study of Various Treatments in Serous or p53 Abnormal Endometrial Cancer [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating various treatments for endometrial cancer with serous histology or p53 abnormalities has been terminat…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma [Phase 2]
A Phase 2 trial evaluating megestrol acetate in combination with rosuvastatin in young women with early endometrial cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: Glove Compression for Chemotherapy-Induced Neuropathy [NA]
A completed clinical trial evaluated glove compression therapy for chemotherapy-induced peripheral neuropathy in patients with gynecologic c…
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus. [NA]
A completed clinical trial evaluating stereotactic pelvic adjuvant radiation therapy for uterine cancers has finished, including endometrial…
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer [Phase 2]
A Phase 2 trial evaluating Letrozole with Palbociclib or placebo in metastatic endometrial cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: Combination Chemotherapy With Nintedanib / Placebo in Endometrial Cancer [Phase 2]
Phase 2 trial evaluating combination chemotherapy with nintedanib versus placebo for endometrial cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: NM32-2668 in Adult Patients With Selected Advanced Solid Tumors [Phase 1]
A Phase 1 trial of NM32-2668 in adults with selected advanced solid tumors has been terminated. The study enrolled multiple tumor types incl…
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: V-Notes Hysterectomy in Patients With Endometrial cáncer Compared With Laparoscopic Surgery (Robotically Assisted or Not): ENOLA TRIAL [NA]
The ENOLA trial comparing V-Notes hysterectomy with laparoscopic surgery for endometrial cancer has completed; results are not provided in t…
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Crizotinib in c-MET Mutation Metastatic/Recurrent/Persistent Endometrial Cancer [Phase 2]
Phase 2 study of crizotinib in c-MET mutation endometrial cancer (metastatic/recurrent/persistent) has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update announcing the termination of a Phase 1/2 study evaluating Fruquintinib in combination with Tislelizumab in adults w…
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations [Phase 2]
A Phase 2 trial evaluating Copanlisib in combination with Fulvestrant in ER+/PR+ cancers with PI3K/PTEN alterations was terminated, with tri…